Literature DB >> 9584161

5' processing of tRNA precursors can Be modulated by the human La antigen phosphoprotein.

H Fan1, J L Goodier, J R Chamberlain, D R Engelke, R J Maraia.   

Abstract

Eukaryotic precursor (pre)-tRNAs are processed at both ends prior to maturation. Pre-tRNAs and other nascent transcripts synthesized by RNA polymerase III are bound at their 3' ends at the sequence motif UUUOH [3' oligo(U)] by the La antigen, a conserved phosphoprotein whose role in RNA processing has been associated previously with 3'-end maturation only. We show that in addition to its role in tRNA 3'-end maturation, human La protein can also modulate 5' processing of pre-tRNAs. Both the La antigen's N-terminal RNA-binding domain and its C-terminal basic region are required for attenuation of pre-tRNA 5' processing. RNA binding and nuclease protection assays with a variety of pre-tRNA substrates and mutant La proteins indicate that 5' protection is a highly selective activity of La. This activity is dependent on 3' oligo(U) in the pre-tRNA for interaction with the N-terminal RNA binding domain of La and interaction of the C-terminal basic region of La with the 5' triphosphate end of nascent pre-tRNA. Phosphorylation of La is known to occur on serine 366, adjacent to the C-terminal basic region. We show that this modification interferes with the La antigen's ability to protect pre-tRNAiMet from 5' processing either by HeLa extract or purified RNase P but that it does not affect interaction with the 3' end of pre-tRNA. These findings provide the first evidence to indicate that tRNA 5'-end maturation may be regulated in eukaryotes. Implications of triphosphate recognition is discussed as is a role for La phosphoprotein in controlling transcriptional and posttranscriptional events in the biogenesis of polymerase III transcripts.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9584161      PMCID: PMC108902          DOI: 10.1128/MCB.18.6.3201

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  40 in total

1.  3'-end-dependent formation of U6 small nuclear ribonucleoprotein particles in Xenopus laevis oocyte nuclei.

Authors:  M P Terns; E Lund; J E Dahlberg
Journal:  Mol Cell Biol       Date:  1992-07       Impact factor: 4.272

2.  Three-dimensional working model of M1 RNA, the catalytic RNA subunit of ribonuclease P from Escherichia coli.

Authors:  E Westhof; S Altman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

3.  Eukaryotic transcription termination factor La mediates transcript release and facilitates reinitiation by RNA polymerase III.

Authors:  R J Maraia; D J Kenan; J D Keene
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

4.  La proteins from Drosophila melanogaster and Saccharomyces cerevisiae: a yeast homolog of the La autoantigen is dispensable for growth.

Authors:  C J Yoo; S L Wolin
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

5.  The RNA polymerase III terminator used by a B1-Alu element can modulate 3' processing of the intermediate RNA product.

Authors:  R J Maraia; D Y Chang; A P Wolffe; R L Vorce; K Hsu
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

6.  Direct interactions between autoantigen La and human immunodeficiency virus leader RNA.

Authors:  Y N Chang; D J Kenan; J D Keene; A Gatignol; K T Jeang
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

7.  La autoantigen enhances and corrects aberrant translation of poliovirus RNA in reticulocyte lysate.

Authors:  K Meerovitch; Y V Svitkin; H S Lee; F Lejbkowicz; D J Kenan; E K Chan; V I Agol; J D Keene; N Sonenberg
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

8.  Capping signals correspond to the 5' end in four eukaryotic small RNAs containing gamma-monomethylphosphate cap structure.

Authors:  G Shumyatsky; S Shimba; R Reddy
Journal:  Gene Expr       Date:  1994

9.  RNA degradation in Escherichia coli regulated by 3' adenylation and 5' phosphorylation.

Authors:  F Xu; S N Cohen
Journal:  Nature       Date:  1995-03-09       Impact factor: 49.962

10.  Use of photoaffinity crosslinking and molecular modeling to analyze the global architecture of ribonuclease P RNA.

Authors:  M E Harris; J M Nolan; A Malhotra; J W Brown; S C Harvey; N R Pace
Journal:  EMBO J       Date:  1994-09-01       Impact factor: 11.598

View more
  56 in total

Review 1.  Recognition of nascent RNA by the human La antigen: conserved and divergent features of structure and function.

Authors:  R J Maraia; R V Intine
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

2.  Transcription efficiency of human polymerase III genes in vitro does not depend on the RNP-forming autoantigen La.

Authors:  S Weser; M Bachmann; K H Seifart; W Meissner
Journal:  Nucleic Acids Res       Date:  2000-10-15       Impact factor: 16.971

Review 3.  La protein and its associated small nuclear and nucleolar precursor RNAs.

Authors:  Richard J Maraia; Robert V Intine
Journal:  Gene Expr       Date:  2002

4.  Structure of the La motif: a winged helix domain mediates RNA binding via a conserved aromatic patch.

Authors:  Gang Dong; Ghadiyaram Chakshusmathi; Sandra L Wolin; Karin M Reinisch
Journal:  EMBO J       Date:  2004-02-19       Impact factor: 11.598

Review 5.  Of proteins and RNA: the RNase P/MRP family.

Authors:  Olga Esakova; Andrey S Krasilnikov
Journal:  RNA       Date:  2010-07-13       Impact factor: 4.942

6.  Nonphosphorylated human La antigen interacts with nucleolin at nucleolar sites involved in rRNA biogenesis.

Authors:  Robert V Intine; Miroslav Dundr; Alex Vassilev; Elena Schwartz; Yingmin Zhao; Yingxin Zhao; Melvin L Depamphilis; Richard J Maraia
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

7.  CK2 is responsible for phosphorylation of human La protein serine-366 and can modulate rpL37 5'-terminal oligopyrimidine mRNA metabolism.

Authors:  Elena I Schwartz; Robert V Intine; Richard J Maraia
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

8.  The La protein functions redundantly with tRNA modification enzymes to ensure tRNA structural stability.

Authors:  Laura A Copela; Ghadiyaram Chakshusmathi; R Lynn Sherrer; Sandra L Wolin
Journal:  RNA       Date:  2006-04       Impact factor: 4.942

9.  Mammalian peptidylglycine alpha-amidating monooxygenase mRNA expression can be modulated by the La autoantigen.

Authors:  Fabienne Brenet; Nadège Dussault; Jonas Borch; Géraldine Ferracci; Christine Delfino; Peter Roepstorff; Raymond Miquelis; L'Houcine Ouafik
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

10.  Unusual noncanonical intron editing is important for tRNA splicing in Trypanosoma brucei.

Authors:  Mary Anne T Rubio; Zdeněk Paris; Kirk W Gaston; Ian M C Fleming; Paul Sample; Christopher R Trotta; Juan D Alfonzo
Journal:  Mol Cell       Date:  2013-10-03       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.